PharmAbcine

PharmAbcine is a professional biotechnology company that utilizes innovative discovery technologies and outstanding human resources to develop fully human therapeutic monoclonal antibodies (mAbs) for the treatment of human diseases, such as cancer and inflammatory conditions. The company's mission is to develop first-in-class and best-in-class monoclonal antibodies for these target diseases. PharmAbcine’s business primarily focuses on out-licensing its candidate therapies and their clinical applications. To achieve this, an internal approach is adopted to build a competitive pipeline and drug discovery platform. The management team possesses expertise in all aspects of therapeutic antibody discovery and development, including marketing, and is supported by world-class scientific advisors who are thought leaders in the fields of biology and medicine.